COPHYLAC EXPECTORANT DROPS
COPHYLAC EXPECTORANT DROPS
Discontinued
DIN Number
02224585
Drug Class
Human
Market Date
Jun 27, 1997
Company
HC
Valeo Pharma Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02224585
AIG Number0304365001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Product Specifications
Dosage FormDrops
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
EMETINE HYDROCHLORIDEActive
Strength: 1.3 MG / ML
Monograph: EMETINE HYDROCHLORIDE
NORMETHADONE HYDROCHLORIDEActive
Strength: 10 MG / ML
Monograph: NORMETHADONE HYDROCHLORIDE
P-HYDROXYEPHEDRINE HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: P-HYDROXYEPHEDRINE HYDROCHLORIDE